Abstract
Acinar cell carcinoma of the pancreas is a rare tumour with specific clinical and paraclinical presentation. Its management is not well codified resulting from its low frequency.
MeSH terms
-
Aged
-
Antineoplastic Agents, Phytogenic / administration & dosage
-
Antineoplastic Agents, Phytogenic / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Biopsy
-
Carcinoma, Acinar Cell* / diagnosis
-
Carcinoma, Acinar Cell* / diagnostic imaging
-
Carcinoma, Acinar Cell* / drug therapy
-
Carcinoma, Acinar Cell* / pathology
-
Carcinoma, Acinar Cell* / surgery
-
Cisplatin / administration & dosage
-
Cisplatin / therapeutic use
-
Etoposide / administration & dosage
-
Etoposide / therapeutic use
-
Follow-Up Studies
-
Humans
-
Immunohistochemistry
-
Male
-
Pancreas / pathology
-
Pancreatectomy
-
Pancreatic Neoplasms* / diagnosis
-
Pancreatic Neoplasms* / diagnostic imaging
-
Pancreatic Neoplasms* / drug therapy
-
Pancreatic Neoplasms* / pathology
-
Pancreatic Neoplasms* / surgery
-
Panniculitis, Nodular Nonsuppurative / pathology
-
Radiography, Abdominal
-
Skin / pathology
-
Time Factors
-
Tomography, X-Ray Computed
-
Treatment Outcome
Substances
-
Antineoplastic Agents, Phytogenic
-
Etoposide
-
Cisplatin